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Summary
Kainate receptors (KAR) are composed of several dis-
tinct subunits and splice variants, but the functional
relevance of this diversity remains largely unclear.
Here we show that two splice variants of the GluR6
subunit, GluR6a and GluR6b, which differ in their C-ter-
minal domains, do not show distinct functional prop-
erties, but coassemble as heteromers in vitro and
in vivo. Using a proteomic approach combining affin-
ity purification and MALDI-TOF mass spectrometry,
we found that GluR6a and GluR6b interact with two
distinct subsets of cytosolic proteins mainly involved
in Ca2+ regulation of channel function and intracellu-
lar trafficking. Guided by these results, we provide
evidence that the regulation of native KAR function
by NMDA receptors depends on the heteromerization
of GluR6a and GluR6b and interaction of calcineurin
with GluR6b. Thus, GluR6a and GluR6b bring in close
proximity two separate subsets of interacting pro-
teins that contribute to the fine regulation of KAR traf-
ficking and function.
Introduction
Targeting and stabilization of glutamate receptors in
specialized neuronal compartments involve interac-
tions with a variety of scaffolding, intracellular traffick-
ing, or signal transduction proteins (Bredt and Nicoll,
2003; Choquet and Triller, 2003; Wenthold et al., 2003).
The variety of proteins recently described as interactors
of AMPA and NMDA receptors have begun to unravel
the cascade of events that leads to the regulation of
these receptors at synaptic sites, especially during syn-
aptic plasticity (Barry and Ziff, 2002; Bredt and Nicoll,
2003; Collingridge et al., 2004; Sheng, 2001; Song and
Huganir, 2002; Wenthold et al., 2003). Far less is known
about ionotropic glutamate receptors of the kainate
type (KARs), which play an important role in the regula-
tion of synaptic transmission and neuronal excitability*Correspondence: mulle@u-bordeaux2.frby acting at either presynaptic, postsynaptic, or extra-
synaptic sites (Huettner, 2003; Jaskolski et al., 2005;
Lerma, 2003). Although the physiological function of
KARs critically depends on their specific localization
and density in these various neuronal compartments,
molecular determinants for the polarized expression of
KARs have not yet been characterized.
KARs are hetero-oligomeric receptor channels as-
sembled from the GluR5, GluR6, GluR7, KA1, and KA2
subunits (Bettler and Mulle, 1995; Lerma, 2003). GluR5,
GluR6, and GluR7 can function as homomeric recombi-
nant receptor channels, although native KARs are likely
to be heteromeric receptors. KA1 and KA2 associate
with these subunits to form heteromeric receptors with
distinct pharmacological properties. GluR5 and GluR6
also coassemble to generate recombinant receptors
with novel functional properties (Cui and Mayer, 1999).
Immunoprecipitation experiments and electrophysio-
logical comparison of KAR subunit-deficient mice have
indicated that brain KARs are composed of various
combinations of subunits. For instance, GluR6, a major
KAR channel-forming subunit, assembles with KA2
(Wenthold et al., 1994) in CA3 pyramidal cells (Con-
tractor et al., 2003) and with GluR5 in hippocampal in-
terneurons (Mulle et al., 2000).
The diversity of KARs is increased by the existence
of splice variants for GluR5, GluR6, and GluR7 receptor
subunits (Bettler and Mulle, 1995; Jaskolski et al., 2005;
Lerma, 2003). We have recently shown that subunit
composition and splice variants regulate membrane
trafficking of KARs (Jaskolski et al., 2004). The C-ter-
minal domains of KA2 and GluR5c carry endoplasmic
reticulum (ER) retention signals (Jaskolski et al., 2004;
Ren et al., 2003a, 2003b), whereas GluR6a contains a
forward trafficking motif necessary for efficient surface
expression (Jaskolski et al., 2004; Yan et al., 2004).
Because KAR subunit splice variants differ in their
C-terminal domains, their differential trafficking is likely
attributable to interactions with distinct subsets of
cytoplasmic trafficking proteins. The C-terminal end of
GluR6a interacts with the PDZ proteins SAP102, SAP97,
PSD-95, PICK1, and GRIP (Coussen et al., 2002; Garcia
et al., 1998; Hirbec et al., 2003). GluR5b and GluR5c
similarly interact with the PDZ domains of PICK1 and
GRIP (Hirbec et al., 2003). It has been proposed that
PICK1 interaction with KAR subunits favors KAR phos-
phorylation and stabilization at synapses through an in-
teraction with GRIP. GluR6a also indirectly interacts
with proteins of the cadherin/catenin complex, trigger-
ing the recruitment of KARs at cell-cell contacts (Cous-
sen et al., 2002).
Here, we report that GluR6a and GluR6b are assem-
bled within the same heteromeric KAR complex in vivo,
even though both splice variants do not differ in their
functional properties. We have questioned the biologi-
cal relevance of this coassembly in terms of trafficking
and function. Using a proteomic approach following af-
finity purification, we have identified subsets of pro-
teins that differentially interact with these two splice
variants. This provides evidence that heteromeric as-
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KAR function. v
d
sResults
r
1Heteromerization of Two C-Terminal
Splice Variants of GluR6 h
GMouse GluR6a and GluR6b (originally named GluR6-2
in mouse) differ by a stretch of 54 and 15 amino acids, n
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Figure 1. Interaction between GluR6a and GluR6b in Mouse Brain w
(A) In situ hybridization with specific oligonucleotide probes for o
GluR6a or GluR6b C-terminal domains. Frontal sections at two dif-
iferent levels of mouse brains show strong hybridization signals in
vthe striatum (left) and the hippocampus (right) with both oligonucle-
(otides. No labeling appeared in sections of GluR6−/− mice taken at
the striatal level (center). m
(B) Characterization of GluR6b-specific antibody. Anti-GluR6b was A
probed against membrane proteins from wild-type or GluR6−/− i
mice brain. The antibody recognized a protein of 115 kDa, which
wwas not detectable in KO mice. Additional bands of lower molecu-
lar weight labeled by the anti-GluR6b antibody likely correspond to
proteolytic fragments, since they were not observed in GluR6−/− E
mice. When equivalent amounts of GluR6a and GluR6b subunits o
expressed in COS-7 cells were loaded on gels, as assessed by T
anti-myc immunoblotting, the antibody recognized specifically the
bGluR6b subunit. Anti-GluR6/R7 antibody is specific for the GluR6a
lform. (C) Coimmunoprecipitation of KAR subunits in mouse brain.
cProteins solubilized from mouse brain membranes were immuno-
precipitated with specific KAR antibodies (IP). Immunoprecipitated (
proteins were detected using corresponding antibodies. KAR sub- i
units each coimmunoprecipitated with one another but did not im- a
munoprecipitate the GluR2 AMPAR subunit.
eluR6b were detected in the same neuronal popula-
ions, in the striatum or principal cells of the hippocam-
us (Figure 1A). No labeling was detected in GluR6−/−
ice for both GluR6a and GluR6b probes.
We thus examined whether GluR6a and GluR6b could
orm heteromers in vivo. For this purpose, we produced
specific antibody directed against the GluR6b subunit
hat recognized a major protein of 115 kDa in a Western
lot loaded with brain membranes from wild-type mice,
ut not from GluR6−/− mice (Figure 1B). The anti-
luR6b antibody labeled a band on membranes pre-
ared from COS-7 cells transfected with GluR6b, but
ot from cells transfected with GluR6a (Figure 1B).
onversely, the GluR6/7 antibody, which is directed
gainst an amino acid sequence present in GluR6a,
oes not recognize GluR6b in COS-7 cells (Figure 1B).
he calculated molecular weight for GluR6b is 98 kDa.
he 115 kDa protein detected in brain membranes
ould correspond to a glycosylated form of GluR6b, as
lready shown for transfected COS-7 cells (Jaskolski et
l., 2004).
Taking advantage of GluR6a and GluR6b antibodies,
e investigated whether GluR6a and GluR6b were part
f the same KAR complex in mouse brain. GluR6a was
mmunoprecipitated by the GluR6b antibody and, con-
ersely, GluR6b was immunoprecipitated by the GluR6/7
GluR6a) antibody (Figure 1C). KA2 subunit also coim-
unoprecipitated with GluR6a and GluR6b, but the
MPA receptor subunit GluR2 did not. These results
ndicate that GluR6a and GluR6b can assemble in vivo
ithin the same KAR complex, together with KA2.
lectrophysiological Characterization
f GluR6a/GluR6b Heteromers
o further confirm that GluR6a and GluR6b can coassem-
le within the same receptor, we used an electrophysio-
ogical assay that takes advantage of the different rectifi-
ation properties of the Q/R editing isoforms of GluR6
Bowie and Mayer, 1995). We first expressed the noned-
ted variants (Q forms) of GluR6a and GluR6b individu-
lly in HEK293 cells. The amplitude of inward currents
voked by fast application of glutamate (1 mM) (Figure
A) was about 10-fold larger for GluR6a(Q) than for
luR6b(Q) (Figure 2B) (GluR6a: 3,914 ± 912 pA, n = 15;
luR6b: 306 ± 69 pA, n = 15), in agreement with differ-
nces in plasma membane targeting of the two splice
ariants (Jaskolski et al., 2004). The evoked currents
esensitized rapidly and almost completely for both
plice variants, as previously described for GluR6a(Q)
eceptors (Bowie and Mayer, 1995; Traynelis and Wahl,
997). Single exponential fits to the desensitizing phase
ad time constants of 9.4 ± 0.5 ms (n = 15) for
luR6a(Q) and 10.2 ± 0.8 ms for GluR6b(Q), which were
ot significantly different (p = 0.4).
The Q to R substitution in GluR6 homomers de-
reases unitary conductance of the channels, reduces
alcium permeability, and transforms the rectification
roperties of these receptors from inwardly rectifying to
inear or slightly outwardly rectifying (Bettler and Mulle,
995; Lerma, 2003). Indeed, the amplitudes of currents
voked at −40 mV in cells expressing GluR6a(R) or
luR6b(R) were much smaller than those for their coun-
erparts with the Q form (Figure 2B), with GluR6b(R) be-
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557Figure 2. GluR6a and GluR6b Form Func-
tional Receptors and Heteromerize
(A) Examples of currents evoked by 1 mM
glutamate in cells transfected with unedited
(Q form) GluR6a (left) or GluR6b (right). The
red lines represent single exponential fits of
the decay, with time constants of 8.5 and 7.6
ms, respectively. (B) Amplitudes of currents
evoked by 1 mM glutamate at −40 mV, in
cells transfected with various GluR6 splice
and editing variants (n = 5 to 15 cells for
each condition). (C) Currents evoked in cells
transfected with the constructs shown above,
at −40 mV and +40 mV. (D) IV curves for glu-
tamate-evoked currents in cells expressing
GluR6a(Q), GluR6b(R), or expressing both sub-
units. (E and F) Currents evoked in cells ex-
pressing GluR6a(Q) and either GluR6a(R) (n =
6 cells) or GluR6b(R) (n = 5 cells) have similar
IV curves (E) and amplitudes (F). In (E), cur-
rent amplitudes for each cell were normal-
ized to the value at −80 mV. Error bars repre-
sent ±SEM.ing barely detectable (Figure 2C). In addition, the Q/R
substitution led to an outwardly rectifying I/V curve
(data not shown). If GluR6a and GluR6b coassemble
within the same receptor, coexpressing GluR6a(Q) and
GluR6b(R) should lead to the expression of receptors
that have a linear I/V curve, which is a strategy that
has been used to monitor the heteromerization of other
GluR subunits (Ayalon and Stern-Bach, 2001; Borto-
lotto et al., 1999; Cui and Mayer, 1999; Paternain et al.,
2000). Coexpression of both splice variants led to much
larger currents at positive potentials than in cells ex-
pressing either GluR6a(Q) or GluR6b(R) alone as homo-
mers (Figures 2C and 2D). These currents cannot be
attributed to the sum of homomeric GluR6a(Q)- and
GluR6b(R)-mediated currents due to the very low am-
plitude of homomeric GluR6b(R) currents. These data
thus indicated that both splice variants were coas-
sembled.
In these experiments, we also confirmed that GluR6a
promoted the surface expression of GluR6b, a splice
variant which is largely retained in the endoplasmic re-
ticulum (ER) when expressed as a homomeric protein
(Jaskolski et al., 2004). We compared cells expressing
GluR6a(Q)/GluR6a(R) and cells expressing GluR6a(Q)/
GluR6b(R). The I/V curves (Figure 2E) and amplitudes
(Figure 2F) of the evoked currents were almost iden-
tical, showing that the two splice variants coassembled
and were targeted to the plasma membrane equally as
well as receptors composed of only GluR6a.
Consequences of the Coassembly
of GluR6a and GluR6b
We examined in further detail the consequences of the
coassembly of GluR6a and GluR6b in regard to the traf-
ficking of KARs to the plasma membrane. For this pur-
pose, we transfected cell lines and neurons in culture
with epitope-tagged GluR6 splice variants. GluR6a (or
myc-GluR6a) and GluR6b (or myc-GluR6b) were cotrans-
fected in COS-7 cells. 98% ± 1% of GluR6b coimmuno-
precipitated with myc-GluR6a, (n = 3 experiments) and
78% ± 11% of GluR6a coimmunoprecipitated with myc-GluR6b (n = 3) (Figure 3A). We used a biotinylation as-
say to quantify the amount of KAR proteins expressed
at the cell surface. The biotinylated fraction of myc-
GluR6a represented 91% ± 8% of the total myc-GluR6a
when expressed alone in COS-7 cells, an amount which
did not vary when coexpressed with GluR6b (Figure 3B)
(92% ± 8%, n = 4). Whereas a large proportion of myc-
GluR6b protein remained in intracellular compartments
(biotinylated fraction, 53% ± 11%, n = 5) when ex-
pressed alone, the large majority of GluR6b (83% ± 7%,
n = 5) was detected in the extracellular fraction when
myc-GluR6b was coexpressed with GluR6a. To exam-
ine the distribution of the two splice variants on the
plasma membrane of COS-7 cells by immunocyto-
chemistry (Figure 3C), we transfected the two splice
variants fused to two different extracellular epitopes
(GPF-GluR6a and myc-GluR6b). When expressed sepa-
rately, both GFP-GluR6a and myc-GluR6b formed ag-
gregates at the plasma membrane, but only GFP-
GluR6a was concentrated at intercellular junctions,
consistent with the specific interaction of GluR6a with
cadherin/catenin proteins (Coussen et al., 2002). In
cells cotransfected with GluR6a and GluR6b, the extra-
cellular localization of myc-GluR6b matched almost ex-
actly that of GFP-GluR6a, and was consequently con-
centrated at intercellular junctions (Figure 3C). In
cultured hippocampal neurons derived from GluR5−/− ×
GluR6−/− mice, myc-GluR6b expressed at the surface
of the dendritic membrane was similarly colocalized
entirely with GPF-GluR6a (Figure 3D). Thus, when
GluR6a and GluR6b are coexpressed in heterologous
cells or in cultured neurons, GluR6b readily coassem-
bles with GluR6a, positively regulating the trafficking of
GluR6b to the plasma membrane and to intercellular
junctions.
Identification of Proteins Interacting with GluR6a
Since both GluR6a and GluR6b were expressed in the
same neuronal populations and coassembled in native
receptors, we hypothesized that heteromerization of
GluR6a and GluR6b could extend the repertoire of cyto-
Neuron
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ization on the Membrane Localization of
KARs
(A) Coimmunoprecipitation of GluR6a and
GluR6b in COS-7 cells. COS-7 cells were co-
transfected either with GluR6a/myc-GluR6b
or with GluR6b/myc-GluR6a. After 24 hr of
expression, immunoprecipitation was per-
formed, using an anti-myc antibody and
Western blots analyzed with anti-myc, anti-
GluR6a, and anti-GluR6b antibodies. Both
myc-tagged subunits were immunoprecipi-
tated (100%) and their counterpart coimmu-
noprecipitated with the tagged subunit.
(B) Surface localization of the receptor sub-
units. Biotinylation assays were performed
on COS-7 cells expressing the different re-
ceptors: biotin binds to extracellular pro-
teins, “input” corresponds to 5% of total
proteins, “extra,” to the biotinylated extra-
cellular protein, and “intra,” to nonbiotiny-
lated intracellular proteins. Heteromerization
of GluR6b with GluR6a promoted the extra-
cellular localization of GluR6b without affect-
ing GluR6a.
(C) Extracellular labeling of GFP-GluR6a
(green) and myc-GluR6b (red) expressed
alone or in combination, in COS-7 cells.
Coexpression of GluR6a and GluR6b pro-
moted cell-surface expression of GluR6b. (D) Extracellular labeling of myc-GluR6b and GFP-GluR6a expressed in combination, in hippocam-
pal neurons in culture. Arrowhead shows expression of GluR6a in the absence of GluR6b. When expressed at the cell surface, GluR6b
colocalized with GluR6a (arrow). Scale bar, 10 m.solic proteins associated with GluR6-containing KARs I
Nand thus might serve to bring into close proximity pro-
teins that are functionally connected. To get a global P
moverview of proteins interacting with the receptor C ter-
minus of both splice variants, we used a proteomic ap- t
lproach that combined either pull-down or coimmuno-
precipitation experiments, 2-D electrophoresis, and s
aidentification of proteins by MALDI-TOF mass spec-
trometry. To identify the proteins that specifically in- m
gteract with the GluR6a C terminus, we performed dif-
ferential analyses of: (1) proteins that were recruited by n
wthe entire GluR6a C terminus fused to GST, but not by
GST alone (Figures 4A and 4B) and (2) proteins that s
cwere immunoprecipitated by the anti-myc antibody
from membrane extracts of transgenic mice expressing t
Nmyc-GluR6a (which represents 25% of the wild-type
GluR6 protein) (Coussen et al., 2002) (Figure 4C) or of p
nwild-type animals (data not shown). Fifteen spots or
trains of spots were present in 2D gels of both GST i
tpull-down experiments with the C-terminal domain of
GluR6a (Figure 4A) and immunoprecipitation with a myc c
(antibody from transgenic mouse brains (Figure 4C), but
were not detected when GST alone was used as a bait p
t(Figure 4B). Among the 15 spots, we were able to iden-
tify six different proteins from their peptide mass finger- s
hprint determined by MALDI-TOF mass spectrometry
(listed in Table 1). These proteins are spectrin (spot 1), f
bContactin chain 1 or F3-contactin (2), dynamin-1 (3), dy-
namitin (4), 14-3-3 γ (5), and calmodulin (6). All these n
tproteins were specifically immunoprecipitated with the
anti-myc antibody from brain extracts of mice express- c
ping myc-GluR6a, indicating that they interact with na-
tive GluR6a in vivo (Figures 4C and 4D). tdentification of Proteins Interacting with GluR6b
o binding partner of GluR6b has yet been identified.
roteins that specifically interact with the GluR6b C-ter-
inal domain were isolated by peptide affinity chroma-
ography, using a synthetic peptide encompassing the
ast 15 C-terminal amino acids of GluR6b as bait and
eparated onto 2D gels (Figure 5). Eight spots that were
pparent in the gels obtained with the GluR6b C-ter-
inal peptide (Figure 5A) were undetectable in the
els obtained by incubating brain extracts with beads
ot coupled to the peptide (Figure 5B). Seven spots
ere unambiguously identified by MALDI-TOF mass
pectrometry (Table 1). These spots corresponded to
almodulin (spot 6), protein phosphatase 2B (both
he catalyticβ and the regulatory α subunits, 7 and 11),
-ethylmaleimide-sensitive fusion protein attachment
rotein γ (NSF, 8), visinin-like protein 1 or VILIP-1 (9),
eurocalcin delta or VILIP-3 (10), and profilin II (12). The
dentity of proteins that display specific interaction with
he GluR6b C terminus in pull-down experiments was
onfirmed by immunoblotting with specific antibodies
Figure 5C). However, interactions detected in peptide
ull-down experiments could be due to nonspecific in-
eractions between the GluR6b peptide and the cyto-
olic proteins, since the amount of peptide is much
igher than in physiological conditions. We thus per-
ormed coimmunoprecipitation experiments from mouse
rain to determine whether these proteins interact with
ative KARs. The GluR6b antibody was not used in
hese experiments because it recognizes a sequence
orresponding to the GluR6b C-terminal domain, likely
recluding the detection of proteins that interact with
he same domain of the GluR6b sequence. We there-
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ing with GluR6a C Terminus
(A and B) GST pull-down using GluR6a C ter-
minus as bait. Cytosolic fraction from mouse
brain (6 mg protein) was incubated with GST
fused to the GluR6a C terminus (A) or GST
alone (B) immobilized on glutathione-Seph-
arose beads. Proteins retained by affinity
were separated by two-dimensional electro-
phoresis and stained with silver. (C) Co-
immunoprecipitation of proteins with myc-
GluR6a. Triton X-100 extract proteins (4 mg
protein) from transgenic mice expressing
myc-GluR6a were immunoprecipitated with
an anti-myc antibody. Immunoprecipitated
proteins were separated onto 2D gels. Typi-
cal gels, representative of three independent
experiments, are illustrated. Arrows indicate
the position of spots identified by MALDI-
TOF mass spectrometry (see Table 1) that
are not detectable in gels from pull-down ex-
periments performed with GST alone (B) or
immunoprecipitation performed from wild-
type mouse (data not shown). (D) Western
blot analysis of proteins that coimmuno-
precipitate with myc-GluR6a. “Input” repre-
sents 5% of the total amount of protein used
in immunoprecipitation. tg, transgenic myc-
GluR6a mice.the anti-myc antibody (Figure 5C). This finding confirms interactions between the GluR6b C-terminal peptide
Table 1. Proteomic Analysis of Proteins Interacting with the C Terminus of the KAR Splice Variants GluR6a and GluR6b
MALDI-TOF MSPosition in Gels
(Figures 4 and 5) Protein Accession Number* Peptides Coverage (%) GluR6a GluR6b
1 Spectrin O88663 32 20.6 + −
2 Contactin chain 1 P12960 18 31.9 + −
3 Dynamin-1 P39053 18 21.4 + −
4 Dynamitin Q99KJ8 12 38.6 + −
5 14-3-3 protein γ P35214 5 26.0 + −
6 Calmodulin P02593 10 70.3 + +
7 Protein phosphatase 2B P48453 19 36.9 − +
catalytic subunit, β
isoform
8 N-ethylmaleimide Q8C1T5 7 26.0 − +
sensitive fusion protein
attachment protein γ
9 Visinin-like protein 1 P28677 9 48.4 − +
(VILIP-1)
10 Neurocalcin delta Q91X97 9 40.1 − +
(VILIP-3)
11 Protein phosphatase 2B Q63810 4 29.6 − +
regulatory subunit 1, α
isoform
12 Profilin II Q9JJV2 5 36.7 − +
*The SWISS-PROT and TrEMBL accession numbers are listed.fore used myc-GluR6a transgenic mice (Coussen et al.,
2002). We first verified that in these mice, native GluR6b
was coimmunoprecipitated with myc-GluR6a, and vice
versa (Figure 5D). Since myc-GluR6a coassembled with
GluR6b, proteins interacting with GluR6b may coimmu-
noprecipitate with myc-GluR6a. Consistent with this
hypothesis, proteins interacting with GluR6b in our
in vitro binding assay were immunoprecipitated withthat the proteins identified do interact with GluR6b
in vivo, and also brings further support to the finding
that GluR6a and GluR6b are part of the same hetero-
meric receptor in vivo.
Strikingly, several GluR6b binding partners that we
have identified are known to function in a Ca2+-depen-
dent manner. This is the case for calmodulin, calcineu-
rin, and the VILIP proteins. We thus checked whether
Neuron
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ing with the GluR6b C Terminus
(A and B) Cytosolic fraction from mouse
brain (4 mg protein) was incubated with a
synthetic peptide encompassing the 15 C-ter-
minal residues of GluR6b and immobilized on
activated Sepharose beads (A) or with the
Sepharose beads alone ([B], control). 2D gels
representative of three experiments per-
formed independently are illustrated. Arrows
indicate the position of spots that were spe-
cifically recruited by the GluR6b C-terminal
peptide. ND, not determined by MALDI-TOF
mass spectrometry. (C) Western blot analy-
sis of proteins recruited by the GluR6b
C-terminal peptide and identified by MALDI-
TOF mass spectrometry. Left panel: peptide-
affinity chromatography using the GluR6b
C-terminal peptide as bait was performed
in the absence (5 mM EDTA) or presence of
5 mM Ca2+. Input represents 5% of the total
amount of protein used in pull-down ex-
periments. Right panel: immunoprecipitation
of proteins identified as binding partners of
GluR6b with an anti-myc antibody in de-
tergent-solubilized extracts from transgenic
myc-GluR6a mice. Proteins in immunoprecip-
itates were detected by immunoblotting. Input
represents 5% of the total amount of protein
used in immunoprecipitation. (D) Coimmuno-
precipitation of GluR6b and myc-GluR6a in
αCaMKII-myc GluR6a transgenic mice. Im-
munoprecipitation was performed using either
anti-myc or anti GluR6b antibodies. Western
blots were then probed with the corresponding
antibodies. Control lane, no primary antibody.
Tg, transgenic myc-GluR6a mice.and its partners were dependent on Ca2+. We incubated f
pcytosolic fractions from mouse brain with GluR6b C-ter-
hminal peptide either in a buffer with Ca2+ (5 mM) or with
MEDTA (5 mM) (Figure 5C). Calmodulin bound to the
iGluR6b C-terminal peptide only in the presence of Ca2+
t(n = 4). Binding of VILIP proteins to the GluR6b C termi-
nnus was also dramatically reduced in the absence of
cCa2+. In contrast, the binding of calcineurin (both the
icatalytic and regulatory subunits) was less sensitive to
rCa2+ than that of calmodulin or the VILIP family pro-
cteins. Finally, interactions between profilin II or NSF and
othe GluR6b C-terminal peptide were not dependent on
Tthe presence of Ca2+.
w
t
Control of the Calcium-Dependent Depression n
of Neuronal KARs by Calcineurin (
Binding to GluR6b t
Since GluR6a and GluR6b interact with distinct subsets l
of protein partners, we hypothesized that the binding i
of protein partners separately to the two GluR6 splice n
variants could induce a crossregulation of the GluR6 a
heteromer. We thus evaluated the importance of the s
heteromerization of GluR6a and GluR6b for native KAR i
function. We focused on the role of calcineurin, be- N
cause its role in the physiology of native and recombi- p
nant KARs has been well documented. Phosphoryla- t
ition of recombinant GluR6a by PKA increases receptorunction (Wang et al., 1993) by increasing its opening
robability (Traynelis and Wahl, 1997), while calcineurin
as the opposite effect (Traynelis and Wahl, 1997).
oreover, in hippocampal neurons in culture, the rise
n intracellular calcium concentration caused by activa-
ion of NMDA receptors or voltage-gated calcium chan-
els causes a transient depression of KAR-mediated
urrents (Ghetti and Heinemann, 2000). This depression
s maximal within 1 s after Ca2+ entry and appears to
equire calcineurin; the recovery from depression is
omplete within 10 s and requires the phosphorylation
f KARs by CamKII (Ghetti and Heinemann, 2000).
herefore, we hypothesized that such a fast depression
ould require direct binding of calcineurin to the recep-
or through the GluR6b subunit. In mouse hippocampal
eurons in culture, KAR currents activated by kainate
300 M) were transiently depressed after prior applica-
ion of NMDA for 3 s (Figure 6A). The depression lasted
ess than 10 s and was most prominent at the earliest
nterval tested, i.e., 2 s (63% ± 5% of control current,
= 10) (Figure 6C). This depression was dependent on
rise in intracellular Ca2+, since no depression was ob-
erved when 10 mM BAPTA was included in the record-
ng solution (90% ± 7% of control current 2 s after
MDA application, n = 3). Then, using the recording
atch pipette, we dialyzed the C-terminal GluR6b pep-
ide (15 amino acids, pepR6b) to compete for proteins
nteracting with this subunit. In pull-down experiments,
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561Figure 6. Disruption of Calcineurin Binding to the GluR6b Subunit
Suppresses Ca2+-Induced Depression of Native KARs
(A) Currents evoked by 300 M kainate (KA) alone (left) or with
previous applications of NMDA (200 M, 3 s) at 2, 4, and 8 s in-
tervals (right). Scale bar, 100 pA, 1 s. The cell was recorded in con-
trol intracellular solution. (B) Competition assay by R6b peptide in
GST-pull-down experiments. Binding of calcineurin was inhibited
by incubation of 100 M of pepR6b peptide. Incubation with the
scramble peptide did not have any effect. (C), Intracellular dialysis
of pepR6b peptide did not affect KA-evoked currents (n = 4 for
each condition). (D) In the presence of pepR6b, application of
NMDA did not depress the KA-evoked current. Experimental condi-
tions as in (A). (E) Summary of experiments as in (A) and (D). Plot
of the ratio of KAR current with or without NMDA preapplication, at
various intervals. White circles, control solution (n = 10); black cir-
cles, with R6b peptide (n = 5); white squares, with scrambled pep-
tide (n = 6). (F) KA-evoked current amplitudes in different cells:
wild-type cells in control solution (WT, n = 15) and solution contain-
ing pepR6b (n = 9); cells from GluR5,6−/− mice, not transfected (KO,
n = 5) or transfected with GluR6a (n = 5), GluR6b (n = 6), or both
(n = 6). (G) Plot as in (E) for cells from KO mice transfected with
GluR6a (n = 4), GluR6b (n = 3), or both (n = 6). Error bars repre-
sent ±SEM.binding of calcineurin to GluR6b was inhibited in a dose-
dependent manner by preincubation with the pepR6b
peptide (Figure 6B). Dialysis of this peptide did not af-
fect the average amplitude nor the run-down of KAR
currents (Figures 6C and 6F), suggesting that binding
of proteins to the GluR6b subunit was not required forplasma membrane targeting on the timescale of min-
utes. However, after more than 5 min of recording to
allow for dialysis of the peptide, the depression of KAR
current caused by NMDA was significantly reduced
compared to the control condition with no peptide
(Figures 6D and 6E) (depression to 86% ± 5% of con-
trol, 2 s after NMDA application, n = 5, p < 0.005). To
test for a nonspecific effect of pepR6b, we dialysed a
scrambled peptide (see Experimental Procedures); the
depression was identical to the one observed without
peptide (Figure 6C, 62% ± 5% of control after 2 s, n =
6). Since the depression was reported to be dependent
on dephosphorylation of KARs by calcineurin, our data
suggest that binding of calcineurin to GluR6b contrib-
utes to the regulation of native KARs following Ca2+
entry.
Thus, coassembly of GluR6a and GluR6b subunits is
likely necessary for the expression of KAR regulation
by intracellular calcium. To test this hypothesis, we
transfected KAR subunits in cultured neurons derived
from GluR5−/− × GluR6−/− mice. Untransfected cells did
not show any current in response to kainate with the
antagonist cocktail (Figure 6F, n = 5). Interestingly,
knock-out neurons transfected with the GluR6a subunit
displayed KAR-mediated currents with amplitudes sim-
ilar to those in untransfected wild-type neurons (Figure
6F), indicating that the transfection protocol did not
lead to gross overexpression of the exogenous recep-
tors. Cells transfected with GluR6b alone displayed sig-
nificantly smaller KAR-mediated currents (Figure 6F, p <
0.05 compared with wild-type), consistent with reduced
plasma membrane targeting of this subunit when ex-
pressed alone (Jaskolski et al., 2004). KARs made with
only one type of GluR6 subunit were not affected by
preapplication of NMDA, and only when the two splice
variants were coexpressed, did NMDA significantly de-
press the receptors (Figure 6G), showing the crucial im-
portance of the heteromerization of two splice variants
for this effect.
Discussion
In the present study, we demonstrate that two splice
variants of the same KAR subunit, GluR6a and GluR6b,
coassemble to form heteromers in heterologous cell
systems and in the brain. We provide evidence that
such heteromerization in recombinant and native KARs
is crucial for crossregulation between the C-terminal
domains of the two splice variants through differential
association with cytosolic proteins. These data high-
light a feature of alternative splicing that allows co-
recruitment of sets of cytosolic interacting proteins
within a glutamate receptor molecular complex.
The C-terminal domain of ionotropic glutamate re-
ceptors contains critical determinants for receptor traf-
ficking and is subject to alternative splicing in most glu-
tamate receptors. Complex interactions of C-terminal
domains with proteins that include PDZ proteins are im-
portant for the regulated trafficking of AMPA and NMDA
receptors, especially during synaptic plasticity. By in situ
hybridization analysis, we indicate that GluR6a and
GluR6b, two splice variants that differ in their C-ter-
minal domain, are expressed in the same neuronal pop-
Neuron
562ulations. This raises the question of the biological sig- a
anificance of the coexpression, in a single neuron, of two
splice variants that do not appear to differ in their func- u
ttional properties. In the present study, we provide
strong evidence that GluR6a and GluR6b coassemble e
eas heteromers in native KARs (likely together with the
KA2 subunit). The essential NR1 subunit of NMDA re- o
Kceptors also exists in several isoforms generated by
alternative splicing (Zukin and Bennett, 1995). Whereas r
psplicing of an exon in the N-terminal domain regulates
the pharmacological properties of NMDARs, alternative f
tsplicing of C-terminal exons influences protein interac-
tions and intracellular trafficking (Wenthold et al., 2003). r
aInterestingly, activity-dependent targeting of NMDA re-
ceptors to synaptic sites is controlled by regulated d
cmRNA splicing of NR1 in the C-terminal domain (Mu et
al., 2003). Despite biochemical evidence that NR1 r
Ysplice variants with different C-terminal domains can
compose native NMDARs (Chazot and Stephenson, f
t1997; also see Sheng et al., 1994), the biological impli-
cation for this coassembly has not yet been directly ad- (
tdressed.
The presence of two GluR6 subunits with distinct o
eC-terminal domains within the same KAR complex
likely extends the possibilities of interaction with cyto- o
tsolic proteins. Accordingly, we have identified two dis-
tinct subsets of protein partners that differentially in- n
cteract with one or the other splice variant. These
include six proteins that bind to the C-terminal domain i
aof GluR6a. These proteins were identified in both GST
pull-down extracts and immunoprecipitates from trans- t
dgenic mice expressing myc-GluR6a receptors in fore-
brain neurons (Coussen et al., 2002). Surprisingly, we a
tdid not detect a set of PDZ proteins such as PSD-95,
SAP102, SAP97, CASK, GRIP, PICK1, and syntenin, s
twhich have been shown to interact with the GluR6a C
terminus in previous studies (Coussen et al., 2002; Gar- t
2cia et al., 1998; Hirbec et al., 2003). This is not due to
the inability of our approach to detect PDZ-based in- t
tteractions, because we have already identified PDZ
proteins as binding partners of the serotonin 5-HT2A (
iand 5-HT2C receptors, which express a canonical class
I PDZ binding motif (SXV), using a similar proteomic i
ascreen (Becamel et al., 2004). One reason for nondetec-
tion of these proteins could be that the PDZ binding m
hmotif of GluR6a (TMA) is less efficient than more classi-
cal class I PDZ recognition motifs (S/TXV/I/L) for bind- c
ring to PDZ proteins. Consistent with this hypothesis,
the mutation of the valine at the position 0 to alanine in c
Gsuch PDZ ligands drastically reduces binding to PDZ
partners (Becamel et al., 2004; Nourry et al., 2003). In p
lparallel, we have identified, using a peptide pull-down
assay, seven proteins interacting with the C-terminal g
edomain of GluR6b. To ascertain that these proteins in-
teracted with GluR6b, we used myc-GluR6a transgenic t
amice in which GluR6b coassembles with myc-GluR6a.
Using an anti-myc antibody we immunoprecipitated e
amyc-GluR6a/GluR6b receptors and confirmed by West-
ern blotting the interaction of all seven proteins iden- a
stified as GluR6b binding partners.
The proteins interacting with GluR6a/GluR6b com-
vprise proteins possibly involved in the assembly and
trafficking of membrane proteins, such as 14-3-3 γ, dy- s
snamin-1, NSF, and dynamitin. 14-3-3 proteins performlarge variety of physiological functions through mech-
nisms that include regulation of enzyme activity, stim-
lation of protein-protein interactions, and control of
he subcellular localization of a binding partner (Berg
t al., 2003). In particular, 14-3-3 proteins play an
ssential role in controlling the function and localization
f ion channels. For instance, in the K+ channel subunit
ir6.2, 14-3-3 proteins interact with a cytoplasmic ER-
etention motif and promote forward trafficking to the
lasma membrane (Yuan et al., 2003). In addition, sur-
ace expression of KCNK3 K+ channels is achieved by
he phosphorylation-dependent binding of 14-3-3 β and
elease from COPI-mediated ER retention (O’Kelly et
l., 2002). Similarly, binding of 14-3-3γ to the C-terminal
omain of GluR6a might be instrumental for the effi-
ient forward trafficking of homomeric and heteromeric
eceptors containing this subunit (Jaskolski et al., 2004;
an et al., 2004). Dynamins are known to be essential
or receptor-mediated endocytosis, although the role of
hese GTPases probably extends beyond endocytosis
Sever, 2002). Endocytosis of AMPA and NMDA recep-
ors is blocked by overexpression of a dominant form
f dynamin (Carroll et al., 1999; Man et al., 2000; Nong
t al., 2003; Wang and Linden, 2000), but the subtype
f dynamin involved in this process has not been iden-
ified. Here we show that GluR6a interacts with dy-
amin-1. Dynamin-1 is concentrated in the presynaptic
ompartment (Gray et al., 2003) and is best known for
ts participation in synaptic vesicle recycling, arguing
gainst the possibility that it plays a role in the endocy-
osis of glutamate receptors in postsynaptic neuronal
omains. However, the presence of GluR6a in presyn-
ptic terminals (Jaskolski et al., 2004) would be consis-
ent with an interaction with dynamin-1. It will be neces-
ary to evaluate whether this interaction is related to
he presynaptic function of KARs in regulating neuro-
ransmitter release (Huettner, 2003; Jaskolski et al.,
005; Lerma, 2003), whether dynamin-1 is involved in
he endocytosis of presynaptic KARs, or whether in-
eraction with dynamin-1 is unrelated to endocytosis
Sever, 2002). Interaction of GluR6b with NSF, a protein
nvolved in membrane fusion, is reminiscent of its role
n the expression of GluR2-containing AMPA receptors
t synapses and its role in long-term depression (Nishi-
une et al., 1998; Song et al., 1998). Further studies
ave elucidated a role for NSF in stabilizing AMPA re-
eptors (Braithwaite et al., 2002) or in promoting the
ecycling of internalized GluR2-containing AMPA re-
eptors (Lee et al., 2004). Dynamitin, which binds to
luR6a, is part of the dynactin complex, a multisubunit
rotein complex required for the activity of the molecu-
ar motor dynein (Schroer, 2004), with a role in retro-
rade as well as anterograde axonal transport (Vallee
t al., 2004). Interaction of GluR6a to dynamitin might
hus be involved in the trafficking of KARs along the
xon. In addition to the proteins identified in the pres-
nt study, a number of PDZ domain binding proteins
re thought to be implicated in the regulated trafficking
nd stabilization of KARs in specific neuronal domains,
uch as PSD-95, GRIP, PICK1, and CASK/Lin proteins.
Two proteins interacting with GluR6a/GluR6b are in-
olved in the organization of the cytoskeleton. First,
pectrin localizes to the postsynaptic density and could
erve to link KARs to the actin cytoskeleton, as in the
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1998). Second, profilin II, a small actin binding protein
implicated in regulating actin polymerization (Witke et
al., 1998), is targeted to dendritic spine heads following
robust synaptic activation and might play a role in sta-
bilizing dendritic spine morphology (Ackermann and
Matus, 2003). Profilin II, by controlling actin stability, is
also involved in the regulation of neuritogenesis by
RhoA activity (Da Silva et al., 2003). Along these lines,
regulation of the motility of hippocampal mossy fiber
filopodia by KARs (Tashiro et al., 2003) might rely on
the interaction of GluR6a/GluR6b with profilin II.
Finally, a third group of proteins interacting with the
C-terminal domains of GluR6b comprises proteins
involved in the Ca2+ regulation of ion channels and re-
ceptors: calcineurin (PP2Bα and PP2Bβ subunits), cal-
modulin (which also binds to GluR6a), VILIP-1, and
VILIP-3. The binding of these proteins to GluR6b de-
pends on Ca2+. VILIP-1 and VILIP-3 belong to a large
family of Ca2+ sensor proteins involved in a variety of
Ca2+-dependent signal transduction cascades, e.g., by
coupling intracellular Ca2+ to the modulation of dif-
ferent types of voltage-gated ion channels (Burgoyne
and Weiss, 2001). The Ca2+-dependent membrane
association, the so-called Ca2+-myristoyl switch that
localizes VILIP proteins to distinct cellular signaling
compartments may be a critical mechanism for the co-
ordinated regulation of signaling cascades (Spilker and
Braunewell, 2003). VILIP-1 modulates the surface ex-
pression and agonist sensitivity of the α4β2 nicotinic
acetylcholine receptor in response to changes in the
intracellular Ca2+ concentration (Lin et al., 2002). There
is no report of a similar effect on glutamate receptors.
In contrast, the Ca2+ binding protein calmodulin has a
well-established role in regulating the functional prop-
erties of NMDA receptors by a direct interaction with
the NR1 subunit (Ehlers et al., 1996). It is widely ac-
cepted that particular patterns of synaptic activity in-
duce a rise of intracellular Ca2+ concentration, which,
in turn, activates kinases and phosphatases capable of
modifying glutamate receptor function. Calcineurin is
the predominant phosphatase in neurons that is acti-
vated by Ca2+ and calmodulin (Winder and Sweatt,
2001).
It is thus important to clarify how Ca2+/calmodulin-
dependent phophatases and Ca2+/calmodulin-depen-
dent kinases regulate the function of KARs in vivo
(Ghetti and Heinemann, 2000). PKA activation enhances
GluR6 function when expressed in HEK cells (Wang
et al., 1993) by increasing open channel probability,
whereas calcineurin decreases open channel prob-
ability (Traynelis and Wahl, 1997). In response to activa-
tion of NMDA receptors, the amplitude of KARs re-
corded in cultured hippocampal neurons decreases,
due to the activation of calcineurin, which likely de-
phosphorylates KARs (Ghetti and Heinemann, 2000).
Because the recovery from depression is inhibited by
blockers of Ca2+/calmodulin-dependent kinase, but is
insensitive to blockers of PKC or PKA, CamKII activity
was thought to be primarily responsible for the phos-
phorylation of native KARs. We took advantage of this
dual regulation by calmodulin and calcineurin to pro-
vide an example in which heteromerization of GluR6
splice variants and their interaction with intracellularproteins are essential for the fine regulation of native
KARs. We found that the inhibition of KAR currents by
prior activation of NMDARs was largely inhibited by in-
fusion of the neuron with a peptide corresponding to
the C-terminal domain of GluR6b that binds calcineurin,
and this inhibition critically depended on the presence
of both GluR6a and GluR6b in the heteromeric receptor
complex. Our data provide an example of cross-inter-
action between the C-terminal domains of GluR6a and
GluR6b where GluR6b is necessary to bind an acces-
sory protein, most likely calcineurin, and GluR6a is the
likely substrate for phosphorylation/dephosphorylation
that affects channel function.
In conclusion, we show that two splice variants of
GluR6, a key subunit involved in the pre- and postsyn-
aptic functions of KARs (Contractor et al., 2001; Mulle
et al., 1998), coassemble in native heteromeric recep-
tors. Coassembly of two splice variants with otherwise
identical functional properties, opens the possibility for
cross-regulation due to the binding of distinct subsets
of proteins to the distinct C-terminal domains of the
two splice variants. In this perspective, interaction of
protein partners to the C-terminal domains of GluR6a
and GluR6b brings together in close physical proximity
functionally coupled proteins such as calmodulin and
calcineurin; PDZ-domain proteins and NSF; and profilin
and dynamin. These results open the way for studying
multiple paired interactions and elucidating their role in
the regulation of physiological and pathological func-
tions of KARs.
Experimental Procedures
cDNA Constructs
GFP and myc cDNAs were introduced after the signal sequence in
the wild-type GluR6a and GluR6b cDNAs, as previously described
(Coussen et al., 2002). Site-directed mutagenesis was performed
using the QuickChange XL kit (Stratagene). cDNAs were se-
quenced and expressed in HEK cells to check for their physiologi-
cal properties.
GluR6b Antibody Production and Purification
Peptide corresponding to the last 15 amino acids of GluR6b (H2N-
KESSIWLVPPYHPDTVC-CONH2) was synthesized by Eurogentec
(Seraing), coupled to a carrier, injected into two rabbits, and then
boosted four times during a period of three months. Antibodies
were purified by peptide affinity.
In Situ Hybridization
Specific probes for GluR6a (5#-TGCCATGGTTTCTTTACCTGGCAA
CCTTCTGTCGTTAAATGTGTG-3#) and GluR6b (5#-AACAGTGTCTG
GATGGTATGGTGGCACTAACCAAATAGAAGATTC-3#) were labeled
by tailing the primers 3# end with 35S-ATP. In situ hybridization was
performed as in Bernard et al. (1992).
Immunocytochemistry
COS-7 cells were transfected with cDNAs using a Fugene kit
(Roche Diagnostics). Primary cultures of hippocampal neurons
were obtained from 1-day-old pups of GluR5−/− × GluR6−/− mutant
mice, as previously described (Jaskolski et al., 2004). They were
transfected with Lipofectamine 2000 (Invitrogen). Cells were incu-
bated 30 min at 20°C with monoclonal anti-GFP or polyclonal anti-
myc antibodies (1:500 dilution) in culture media and immediately
fixed with paraformaldehyde. The secondary fluorescent antibod-
ies (anti-mouse antibody, Alexa-488, and anti-rabbit antibody,
Alexa-568) were incubated for 30 min at 20°C. Coverslips were then
Neuron
564mounted with Prolong Antifade Kit (Molecular Probes). Pictures i
iwere taken with an Axioplan Zeiss microscope
C
wElectrophysiology
1Electrophysiological Recordings of Glutamate-Evoked
dCurrents in HEK293 Cells
iCells were transfected using the Fugene kit with untagged GluR6
tsubunits and GFP at a ratio of 2:1 or 1:1:1 when one or two sub-
cunits were cotransfected with GFP. For recordings, 1 day after
transfection, cells were placed in HEPES-buffered solution (HBS)
containing 145 mM NaCl, 2 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 10 T
mM glucose, 10 mM HEPES, adjusted to 320 mOsm and pH 7.4 o
with NaOH, at room temperature. Cells were observed with fluores- P
cent illumination, and isolated, brightly fluorescent cells were cho- a
sen. Recording pipettes were filled with a solution containing 122 l
mM CsCl, 2 mM NaCl, 2 mM MgCl2, 10 mM EGTA, 10 mM HEPES, s
4 mM Na2ATP, 0.06 mM spermine, adjusted to 310 mOsm, and pH w
7.2 with CsOH. Pipette resistance was 2–4 M. After a whole-cell 5
recording was achieved, the cell was gently pulled and lifted off a
the coverslip and placed under the flow of a theta tube. Fast appli- b
cation was achieved by moving the theta tube laterally with a t
piezoelectric device (Burleigh). Glutamate (1 mM) was applied ev- S
ery 20 to 30 s. Cells were kept at −40 mV. I-V curves were obtained a
by stepping the voltage 100 ms before the glutamate application. i
Electrophysiological Recordings of Neurons t
Primary cultures of hippocampal neurons were prepared from wild- s
type or GluR5−/− × GluR6−/− mice. For transfection of neurons, we a
used Lipofectamine 2000 to cotransfect untagged GluR6 subunits c
and GFP at a ratio of 2:1 (one subunit) or 1:1:1 (two subunits). Neu- t
rons were transfected 7–8 days after plating, and recorded 1 to 4 s
days after transfection. Overall, neurons were recorded 7–15 days
after plating. Cells were bathed in HBS at room temperature, and a
under the flow of a three-barrel pipette containing HBS without l
MgCl2, which contained 1 M TTX, 100 M GYKI 53655, 50 M t
picrotoxine, and 2 M glycine. One of the barrels contained, in ad- α
dition, 200 M NMDA, and another, 300 M kainate. Kainate was T
applied for 1 s every minute. To test for KAR depression by NMDAR m
activation, NMDA was applied for 3 s, at intervals of 2 s, 4 s, or t
8 s before kainate. Recording pipettes contained 141 mM CsCl, 2 (
mM NaCl, 2 mM MgCl2, 0.5 mM EGTA, 10 mM HEPES, and 4 mM (
Na2ATP. In some experiments, EGTA was replaced by 10 mM I
BAPTA. In other experiments, 100 M of peptides corresponding to (
the last 15 amino acids of GluR6b or to a 15 amino acid scrambled d
sequence (H2N-KSWPHTDPSIYVLEPVC-CONH2) was added, to-
gether with a cocktail of antiproteases (pepstatin, aprotinin, leu-
Speptin, and pefabloc [10 g/ml each]).
O
8Preparation of Brain Protein Extract
t
For each experiment, proteins from three mouse brains were ex-
b
tracted and solubilized by 1% Triton X-100 as in Coussen et al.
a
(2002). The resulting supernatant was the Triton X-100 extract used
i
for immunoprecipitation experiments.
a
b
Immunoprecipitation
Myc-GluR6 proteins were immunoprecipitated from αCaMKIIa-
Amyc-GluR6 transgenic lines, as previously described (Coussen et
Tal., 2002). The anti-myc antibody was linked to protein-G agarose
awith 20 mM dimethyl pimelimidate during 30 min at room temper-
(ature. Immunoprecipitated proteins were eluted with either 350 l
risoelectrofocusing medium (7 M urea, 2 M thiourea, 4% CHAPS,
fampholines [preblended, pI, 3.5–9.5, 8 mg/ml; Amersham Biosci-
(ences], 100 mM DTT, 0.2% tergitol NP7 [Sigma], and traces of bro-
tmophenol blue), for two-dimensional (2D) electrophoresis, or 100
tl SDS sample buffer (50 mM Tris-HCl [pH, 6.8], 2% SDS, 10%
Lglycerol, 100 mM DTT, and traces of bromophenol blue), for immu-
anoblotting.
Peptide Affinity Chromatography A
Affinity chromatography experiments were performed using either
the entire GluR6a C-terminal domain (70 amino acids) fused to GST T
R(GST-GluR6a pull-down) or the synthetic GluR6b peptide. This pep-
tide was coupled via its N-terminal extremity to activated CH-Seph- t
tarose 4B (Amersham Biosciences), according to the manufacturer’snstructions. Cytosolic protein extracts from mice brain (6 mg) were
ncubated with either GST-GluR6a, GST (5 mg each) or GluR6b
-terminal peptide (2 mg). For bidimensional analysis, proteins
ere eluted with reduced glutathione (10 mM), precipitated with
0% trichloroacetic acid, and solubilized in isoelectrofocusing me-
ium. For Western blot analysis, GST samples were resuspended
n SDS sample buffer. In competition assays, R6b or scramble pep-
ides were incubated during the reaction at concentrations indi-
ated in the figure.
wo-Dimensional Electrophoresis and Identification
f Proteins by MALDI-TOF Mass Spectrometry
roteins were first separated according to their isoelectric point
long linear immobilized pH-gradient (IPG) strips (pH, 3–10, 18 cm
ong; Amersham Biosciences). Sample loading for the first dimen-
ion was performed by passive in-gel reswelling. The IPG strips
ere then equilibrated for 10 min in a buffer containing 6M urea,
0 mM Tris-HCl (pH, 6.8), 30% glycerol, 2% SDS, 10 mg/ml DTT,
nd bromophenol blue and then equilibrated for 15 min in the same
uffer containing 15 mg/ml iodoacetamide instead of the DTT. For
he second dimension, the strips were loaded onto vertical 12.5%
DS polyacrylamide gels. Gels were silver stained (Shevchenko et
l., 1996). Gels to be compared were always processed and stained
n parallel. Gels were scanned using a computer-assisted densi-
ometer (Amersham). Spot detection, gel alignment, background
ubstraction, and spot quantification were performed with the Mel-
nie 5 software (Amersham), using four gels for each experimental
ondition. To correct for variability resulting from silver staining,
otal spot volume normalization was performed after background
ubstraction for each gel.
Protein spots that were not detected in control gels were excised
nd digested in gel using trypsin (Promega). Digest products were
oaded onto the target of an Ultraflex MALDI-TOF mass spectrome-
er (Bruker-Franzen Analytik) and mixed with the same volume of
-cyano-4-hydroxy-trans-cinnamic acid (10 mg/ml in acetonitrile-
FA, 50%–0.1%; Sigma). Analysis was performed in reflectron
ode with an accelerating voltage of 20 kV and a delayed extrac-
ion of 400 ns. Spectra were analyzed using the XTOF software
Bruker-Franzen Analytik) and auto-proteolysis products of trypsin
Mr: 842.51, 1045.56, 2211.10) were used as internal calibrates.
dentification of proteins was performed using the Mascot software
available online at http://www.matrixscience.com), as previously
escribed (Becamel et al., 2002).
urface Biotinylation
ne day after transfection, COS-7 cells were washed with PBS (pH,
.0) and incubated with 0.5 mg/ml of EZ-Link Sulfo-NHS-S-LC-Bio-
in (Pierce) in PBS for 30 min at 4°C. Cells were scraped in lysis
uffer containing 25 mM HEPES, 150 mM NaCl, 1% Triton X-100,
nd protease inhibitors. After centrifugation, the supernatant was
ncubated with immobilized Streptavidin beaded agarose overnight
t 4°C and extensively washed. Samples were analyzed by Western
lot with antibodies corresponding to the proteins of interest.
ntibodies
he sources of antibodies used were: Anti-GluR6a/GluR7 (06-309),
nti-KA2 (06-315), anti-myc polyclonal (06-549), anti-calmodulin
05-173), and anti-Dynamin-1 (05-319), from Upstate; anti-calcineu-
in (AB-1694), from Chemicon; anti-myc monoclonal (1 667 149),
rom Roche; anti-14-3-3 (sc-731), from Santa Cruz; anti-spectrin
S 3396), from Sigma; and anti-NSF (123 002), from Synaptic Sys-
ems; anti-F3-contactin, the gift of C. Faivre Sarrailh; anti-profilin II,
he gift of W. Witke; and anti-VILIP 1 and anti-VILIP 3, the gift of D.
adant. GluR6b antibodies (Seraing) were produced as described
bove.
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